全文获取类型
收费全文 | 3078篇 |
免费 | 115篇 |
国内免费 | 14篇 |
专业分类
耳鼻咽喉 | 11篇 |
儿科学 | 14篇 |
妇产科学 | 23篇 |
基础医学 | 241篇 |
口腔科学 | 762篇 |
临床医学 | 244篇 |
内科学 | 702篇 |
皮肤病学 | 30篇 |
神经病学 | 199篇 |
特种医学 | 144篇 |
外科学 | 278篇 |
综合类 | 189篇 |
预防医学 | 116篇 |
眼科学 | 10篇 |
药学 | 175篇 |
中国医学 | 29篇 |
肿瘤学 | 40篇 |
出版年
2024年 | 4篇 |
2023年 | 94篇 |
2022年 | 83篇 |
2021年 | 141篇 |
2020年 | 107篇 |
2019年 | 253篇 |
2018年 | 278篇 |
2017年 | 141篇 |
2016年 | 83篇 |
2015年 | 66篇 |
2014年 | 206篇 |
2013年 | 178篇 |
2012年 | 99篇 |
2011年 | 127篇 |
2010年 | 85篇 |
2009年 | 102篇 |
2008年 | 92篇 |
2007年 | 142篇 |
2006年 | 72篇 |
2005年 | 78篇 |
2004年 | 65篇 |
2003年 | 39篇 |
2002年 | 16篇 |
2001年 | 25篇 |
2000年 | 19篇 |
1999年 | 20篇 |
1998年 | 18篇 |
1997年 | 15篇 |
1996年 | 9篇 |
1995年 | 4篇 |
1994年 | 7篇 |
1993年 | 31篇 |
1992年 | 12篇 |
1991年 | 12篇 |
1990年 | 8篇 |
1989年 | 12篇 |
1988年 | 4篇 |
1985年 | 44篇 |
1984年 | 55篇 |
1983年 | 29篇 |
1982年 | 56篇 |
1981年 | 26篇 |
1980年 | 22篇 |
1979年 | 24篇 |
1978年 | 42篇 |
1977年 | 13篇 |
1976年 | 21篇 |
1975年 | 46篇 |
1974年 | 40篇 |
1973年 | 37篇 |
排序方式: 共有3207条查询结果,搜索用时 15 毫秒
71.
72.
Vishal Kapur MD Nathaniel R. Smilowitz MD Giora Weisz MD 《Catheterization and cardiovascular interventions》2014,83(6):915-921
A remote‐controlled, robotic system was developed to address procedural challenges and occupational hazards associated with traditional percutaneous coronary intervention (PCI). The PRECISE (Percutaneous Robotically Enhanced Coronary Intervention) Study demonstrated the safety and feasibility of the robotic system. We report four cases of complex coronary interventions demonstrating the capabilities of robotic‐enhanced PCI to treat multilesion, multivessel coronary disease, saphenous venous graft disease, and an ST‐elevation myocardial infarction. The robotic system offers enhanced visibility, precise measurement, accurate stent positioning, improved ergonomics, and superior operator protection from radiation. © 2013 Wiley Periodicals, Inc. 相似文献
73.
Qian Yang Lihua Li Juan Zhang Guoliang Shao Chengjie Zhang Bin Zheng 《Journal of digital imaging》2014,27(1):152-160
Dynamic contrast material-enhanced magnetic resonance imaging (DCE-MRI) of breasts is an important imaging modality in breast cancer diagnosis with higher sensitivity but relatively lower specificity. The objective of this study is to investigate a new approach to help improve diagnostic performance of DCE-MRI examinations based on the automated detection and analysis of bilateral asymmetry of characteristic kinetic features between the left and right breast. An image dataset involving 130 DCE-MRI examinations was assembled and used in which 80 were biopsy-proved malignant and 50 were benign. A computer-aided diagnosis (CAD) scheme was developed to segment breast areas depicted on each MR image, register images acquired from the sequential MR image scan series, compute average contrast enhancement of all pixels in one breast, and a set of kinetic features related to the difference of contrast enhancement between the left and right breast, and then use a multi-feature based Bayesian belief network to classify between malignant and benign cases. A leave-one-case-out validation method was applied to test CAD performance. The computed area under a receiver operating characteristic (ROC) curve is 0.78 ± 0.04. The positive and negative predictive values are 0.77 and 0.64, respectively. The study indicates that bilateral asymmetry of kinetic features between the left and right breasts is a potentially useful image biomarker to enhance the detection of angiogenesis associated with malignancy. It also demonstrates the feasibility of applying a simple CAD approach to classify between malignant and benign DCE-MRI examinations based on this new image biomarker. 相似文献
74.
Erik P A van Iperen Suthesh Sivapalaratnam S Matthijs Boekholdt G Kees Hovingh Stephanie Maiwald Michael W Tanck Nicole Soranzo Jonathan C Stephens Jennifer G Sambrook Marcel Levi Willem H Ouwehand John JP Kastelein Mieke D Trip Aeilko H Zwinderman 《European journal of human genetics : EJHG》2014,22(6):809-813
In recent years, multiple loci dispersed on the genome have been shown to be associated with coronary artery disease (CAD). We investigated whether these common genetic variants also hold value for CAD prediction in a large cohort of patients with familial hypercholesterolemia (FH). We genotyped a total of 41 single-nucleotide polymorphisms (SNPs) in 1701 FH patients, of whom 482 patients (28.3%) had at least one coronary event during an average follow up of 66 years. The association of each SNP with event-free survival time was calculated with a Cox proportional hazard model. In the cardiovascular disease risk factor adjusted analysis, the most significant SNP was rs1122608:G>T in the SMARCA4 gene near the LDL-receptor (LDLR) gene, with a hazard ratio for CAD risk of 0.74 (95% CI 0.49–0.99; P-value 0.021). However, none of the SNPs reached the Bonferroni threshold. Of all the known CAD loci analyzed, the SMARCA4 locus near the LDLR had the strongest negative association with CAD in this high-risk FH cohort. The effect is contrary to what was expected. None of the other loci showed association with CAD. 相似文献
75.
76.
《JACC: Cardiovascular Imaging》2014,7(11):1119-1127
ObjectivesThe purpose of this study was to compare myocardial blood flow (MBF) and myocardial flow reserve (MFR) estimates from rubidium-82 positron emission tomography (82Rb PET) data using 10 software packages (SPs) based on 8 tracer kinetic models.BackgroundIt is unknown how MBF and MFR values from existing SPs agree for 82Rb PET.MethodsRest and stress 82Rb PET scans of 48 patients with suspected or known coronary artery disease were analyzed in 10 centers. Each center used 1 of 10 SPs to analyze global and regional MBF using the different kinetic models implemented. Values were considered to agree if they simultaneously had an intraclass correlation coefficient >0.75 and a difference <20% of the median across all programs.ResultsThe most common model evaluated was the Ottawa Heart Institute 1-tissue compartment model (OHI-1-TCM). MBF values from 7 of 8 SPs implementing this model agreed best. Values from 2 other models (alternative 1-TCM and Axially distributed) also agreed well, with occasional differences. The MBF results from other models (e.g., 2-TCM and retention) were less in agreement with values from OHI-1-TCM.ConclusionsSPs using the most common kinetic model—OHI-1-TCM—provided consistent results in measuring global and regional MBF values, suggesting that they may be used interchangeably to process data acquired with a common imaging protocol. 相似文献
77.
《JACC: Cardiovascular Imaging》2014,7(10):1001-1010
ObjectivesThe purpose of this study was to evaluate prevalence, progression, treatment, and outcome of silent coronary artery disease (CAD) in asymptomatic patients with diabetes (DM) at high coronary risk.BackgroundDespite the close association of diabetes and CAD, general CAD screening in asymptomatic patients with DM is discouraged even though outcome data in patients at high coronary risk are lacking.MethodsProspective multicenter outcome study—with a pilot randomized treatment substudy. The study comprised 400 asymptomatic patients with DM (type 2) without history or symptoms of CAD at high CAD risk. They underwent clinical evaluation and myocardial perfusion single-photon emission computed tomography (MPS) at baseline and after 2 years. Patients with normal MPS received usual care; those with abnormal MPS received medical or combined invasive and medical management.ResultsAn abnormal MPS was found in 87 of 400 patients (22%). In patients with normal MPS, MACE occurred in 2.9% and ischemia or new scar in 3.2%. Patients with abnormal MPS had more MACE (9.8%; hazard ratio: 3.44; 95% confidence interval [CI]: 1.32 to 8.95; p = 0.011) and ischemia or new scar (34.2%; odds ratio: 15.91; 95% CI: 7.24 to 38.03; p < 0.001) despite therapy, resulting in “overt or silent CAD progression” of 35.6% versus 4.6% (odds ratio: 11.53; 95% CI: 5.63 to 24.70; p < 0.001). Patients with abnormal MPS randomized to medical versus invasive-medical strategies had similar event rates (p = 0.215), but more ischemic or new scar findings (54.3% vs. 15.8%; p < 0.001).ConclusionsHigh-risk asymptomatic patients with DM and normal MPS (78%) have a low rate of first manifestations of CAD. Patients with abnormal MPS at baseline (22%) have a 7-fold higher rate of progression to “overt or silent CAD,” despite therapy. Randomized patients’ outcomes suggest that a combined invasive and medical strategy for silent CAD may reduce scintigraphic but not symptomatic CAD progression versus medical therapy alone. (Trial of Invasive versus Medical therapy of Early coronary artery disease in Diabetes Mellitus ISRCTN87953632). 相似文献
78.
《JACC: Cardiovascular Interventions》2014,7(10):1128-1137
ObjectivesThis study sought to evaluate the long-term prognostic capacity of the SYNTAX (Synergy Between Percutaneous Coronary Intervention With Taxus and Cardiac Surgery) score II (SS-II) and compare it with other risk scores among patients undergoing left main percutaneous coronary intervention (LM-PCI).BackgroundRecently, the SS-II was developed in an attempt to individualize and help the decision-making process between PCI and coronary artery bypass graft (CABG) surgery in the management of complex coronary artery disease (CAD). However, there is a paucity of data regarding the utility of SS-II in patients undergoing LM-PCI.MethodsData from 1,528 consecutive patients from a single center undergoing unprotected LM-PCI were prospectively collected. The SS-II and other scores were then derived using patients’ baseline clinical characteristics. Patients were stratified according to tertiles of SS-II for PCI: SS-II ≤21 (n = 508), SS-II >21 and ≤28 (n = 480), and >28 (n = 540). Predictive capability for long-term mortality was compared between angiographic scores and scores combining both angiographic and clinical variables.ResultsAt a mean follow-up of 4.4 years, mortality in the first, second, and third SS-II tertiles was 1.8%, 3.5%, and 9.4%, respectively (p < 0.0001). Multivariate analysis showed SS-II to be a strong independent predictor of mortality (hazard ratio: 1.76, 95% confidence interval: 1.10 to 2.82; p = 0.02) after LM-PCI. When compared with the angiographic SS, scores combining both clinical and angiographic variables, such as the SS-II, were superior in terms of long-term prognostication.ConclusionsResults of this large series of consecutive patients who underwent unprotected LM-PCI suggested that the SS-II has better long-term prognostic power in terms of mortality compared with the original purely angiographic SS. 相似文献
79.
80.
免疫性血小板减少症(immune thrombocytopenia,ITP)是一种因免疫系统介导的血小板破坏过多进而导致血小板减少的疾病,具有高出血风险。冠心病(coronary artery disease,CAD)和经皮冠状动脉介入(percutaneous coronary intervention,PCI)术后的患者需要常规抗血小板治疗,与ITP的治疗相矛盾。本文报道1例ITP合并急性冠脉综合征(acute coronary syndrome,ACS)行PCI术的老年男性,因血小板数量低下、出血风险高而未行充分抗血小板治疗,导致ACS数次发作,于原冠脉支架内形成血栓,病程中数次行PCI术并调整抗血小板治疗方案和激素治疗剂量,以期为这类患者的临床处理提供参考。 相似文献